Commercialization of Biobanks
2012 (English)In: Biopreservation and Biobanking, ISSN 1947-5535, E-ISSN 1947-5543, Vol. 10, no 1, 45-47 p.Article in journal (Refereed) Published
Biobank policy and regulations profoundly vary between different societies. One area with profound differences in culture and tradition concerns commercialization, and the possibility of using the human body as a capital resource. In the United States there is acceptance of this possibility, whereas European law is based on principles that categorically prohibit selling parts of the human body. We suggest that questions of commercialization in the area of biobanking must be considered in relation to different ethical values, notably the principle of best possible use of collected biobank materials for the benefit of vital patient interests.
Place, publisher, year, edition, pages
2012. Vol. 10, no 1, 45-47 p.
IdentifiersURN: urn:nbn:se:uu:diva-171502DOI: 10.1089/bio.2011.0041ISI: 000300540800008OAI: oai:DiVA.org:uu-171502DiVA: diva2:511206